Thank you, John. Fiscal second quarter revenue was $540.6 million, which was a September quarter record, and as John mentioned earlier, represents the fifth consecutive quarter of record revenue for the corresponding fiscal period. Revenue was up 37% quarter-over-quarter and up 16% from a year ago. A strong performance during the quarter resulted in revenue above the high end of our guidance range and was driven by higher smartphone unit volumes associated with our customers' new product ramps. On a year-over-year basis, the revenue performance was driven by higher ASPs, an increase in smartphone unit volumes and high performance mixed signal content gains. I'd like to highlight the outstanding execution by the supply chain organization and the entire Cirrus team in helping deliver these strong results. Turning to gross margin. Non-GAAP gross profit in the quarter was $271.6 million and non-GAAP gross margin was 50.2%. This was roughly in line with the midpoint of the guidance range we had provided. On a sequential basis, gross margin was down primarily due to higher reserves, product mix and increased supply chain costs. The year-over-year change in gross margin reflects an increase in supply chain costs that came into effect in January 2002 and to a lesser extent higher reserves. Non-GAAP operating expenses in the quarter were $123.9 million, up $4.4 million sequentially. I'd note that operating expenses came in below the midpoint of our guidance range despite higher revenue as higher variable compensation was more than offset by lower product development costs and employee related expenses. We intend to continue to invest strategically in new product development while controlling discretionary spending. Non-GAAP operating income was $147.7 million in the second quarter or 27% of revenue. And finally on the P&L non-GAAP net income in the second quarter was $114.5 million or $1.99 per share. Let me now turn to the balance sheet. Our balance sheet continues to remain strong and we ended the second quarter of fiscal year 2023 with approximately $428 million in cash and cash equivalents, and we had $300 million undrawn on our revolver. Our ending cash balance was down roughly $25.8 million from the prior quarter, primarily due to cash flow from operations, offset by stock repurchases during the quarter. Specifically, we generated cash flow from operations of $36 million during the September quarter, which is a seasonally slower quarter for cash generation due to the timing of product ramps. We have no debt outstanding, and inventory was $165 million, down $10 million sequentially, and days of inventory was 56 days in Q2 down 27 days sequentially as we ship product to support our customers’ new product ramps. And turning to cash flow. As I mentioned earlier, cash flow from operations was $36 million in the September quarter. Free cash flow for the quarter was $25.7 million. In Q2, we utilized $50 million to repurchase roughly 583,000 shares of our common stock at an average price of $85.78. As of the end of Q2 fiscal year 2023, we had $586.1 million remaining in our share repurchase authorization. We executed an additional $25 million in stock buybacks subsequent to the quarter end to repurchase roughly 376,000 shares at an average price of $66.46 as part of a 10b5-1 trading plan. We expect to continue to return capital in the form of stock repurchases, which we believe will provide a long-term benefit to shareholders going forward. And now on to the guidance. For the fiscal third quarter of 2023, we expect revenue in the range of $520 million to $580 million. We expect gross margin to range from 49% to 51%. Non-GAAP operating expense is expected to be flat sequentially in the range of $120 million to $126 million as higher product development cost is offset by lower SG&A expense. We will continue to control discretionary spending but invest strategically in product development to drive long-term growth. On the tax front, as we have previously discussed, due largely to a tax rule effective this year that requires companies to capitalize and amortize R&D expenses rather than deduct them in the current year, we continue to expect our fiscal 2023 non-GAAP effective tax rate to be approximately 23% to 25%. We maintain our expectation that under this rule, our effective tax rate will decrease and may return to a normalized range in about five years as additional years of R&D expenses are amortized for tax purposes, absent any changes to the legislation. However, there appears to be strong legislative support for delaying or eliminating this rule, which we are watching closely. I note that without the impact of this rule, our non-GAAP effective tax rate would be in our more typical mid-teens range. In closing, we had a strong Q2 fiscal year 2023 as we executed well to deliver these results. Going forward, we will continue to focus on the best opportunities to enable the company to grow both revenue and profitability over the long-term. And finally, before we begin the Q&A, I’d like to note that while we understand there is intense interest related to our largest customer, in accordance with Cirrus Logic company policy, we will not discuss specifics about our business relationship. With that, let me now turn the call to Chelsea to start the Q&A session.